CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 40.94 USD 1.14% Market Closed
Market Cap: 3.5B USD
Have any thoughts about
CRISPR Therapeutics AG?
Write Note

P/OCF
Price to OCF

-18.5
Current
-12.5
Median
21.9
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-18.5
=
Market Cap
3.5B USD
/
Operating Cash Flow
-188.8m USD
All Countries
Close
Market Cap P/OCF
CH
CRISPR Therapeutics AG
NASDAQ:CRSP
3.5B USD -18.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 640.8
US
Abbvie Inc
NYSE:ABBV
318.1B USD 19.3
US
Amgen Inc
NASDAQ:AMGN
142.2B USD 19.6
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD -124.9
US
Epizyme Inc
F:EPE
94.1B EUR -469.4
AU
CSL Ltd
ASX:CSL
135.7B AUD 30.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -75.8
NL
argenx SE
XBRU:ARGX
36.2B EUR -144.9
 
CH
CRISPR Therapeutics AG
NASDAQ:CRSP
Average P/OCF: 19.9
Negative Multiple: -18.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 640.8
US
Abbvie Inc
NYSE:ABBV
19.3
US
Amgen Inc
NASDAQ:AMGN
19.6
US
Gilead Sciences Inc
NASDAQ:GILD
11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.4
AU
CSL Ltd
ASX:CSL
30.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -144.9

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More